An FDA-approved monoclonal antibody drug used to treat advanced bladder cancer demonstrated poor efficacy in a recent clinical trial published in The Lancet Oncology.
University of Toronto physicians say more research is needed on the popular antiviral drug remdesivir, after they documented a rare case of bradycardia in a male […]